Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis.

Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis.
复制标题

DOI:
10.1097/aog.0000000000001899
复制
发表时间:
2017-03
影响因子:
7.2
通讯作者:
Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium
Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium
中科院分区:
医学2区
文献类型:
--
作者:
Boggess KA;Tita A;Jauk V;Saade G;Longo S;Clark EAS;Esplin S;Cleary K;Wapner R;Letson K;Owens M;Blackwell S;Beamon C;Szychowski JM;Andrews W;Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium

文献摘要

被引文献

相似文献

在一项切口前广谱抗生素预防的随机临床试验中,确定剖宫产后产妇感染的临床危险因素。我们对一项随机临床试验进行了有计划的二次分析。患者妊娠≥24周,经至少4小时胎膜破裂或阵痛后剖宫产分娩。所有的参与者都接受了标准的切口前预防,并随机接受阿奇霉素或安慰剂。本分析的主要结局是母体感染:产后6周内发生子宫内膜炎、伤口感染(浅表或深部)或其他感染的复合结局。在控制阿奇霉素分配后,确定了与母体感染相关的母体临床特征。将这些母体因素纳入母体感染的多变量logistic回归模型。在2013名患者中,1019名随机接受阿奇霉素治疗。总体而言,177例(8.8%)发生剖宫产后母体感染。在最终调整后的模型中,与参照组相比,非横向子宫切口、膜破裂持续时间bbbb6小时、手术持续时间bbbb49分钟的黑人妇女,其母体感染的几率更高(所有调整后的优势比均为~ 2);阿奇霉素与母体感染几率较低相关(校正优势比为0.4,95%可信区间为0.3-0.6)。尽管在切开前使用阿奇霉素为基础的广谱抗生素预防,剖宫产后产妇感染仍然是发病率的重要来源。认识到风险因素可能有助于指导创新的预防战略。
To identify maternal clinical risk factors for postcesarean maternal infection in a randomized clinical trial of preincision extended-spectrum antibiotic prophylaxis. We conducted a planned secondary analysis of a randomized clinical trial. Patients were ≥ 24 weeks of gestation and delivered by cesarean delivery after a minimum of 4 hours of ruptured membranes or labor. All participants received standard preincision prophylaxis and were randomized to receive azithromycin or placebo. The primary outcome for this analysis is maternal infection: a composite outcome of endometritis, wound infection (superficial or deep), or other infections occurring up to 6 weeks postpartum. Maternal clinical characteristics associated with maternal infection, after controlling for azithromycin assignment, were identified. These maternal factors were included in a multivariable logistic regression model for maternal infection. Of 2,013 patients, 1,019 were randomized to azithromycin. Overall, 177 (8.8%) had postcesarean maternal infection. In the final adjusted model, compared to the reference groups, women of Black race–ethnicity, with a nontransverse uterine incision, with duration of membrane rupture > 6 hours, and surgery duration > 49 minutes, were associated higher odds of maternal infection (all with adjusted odds ratios of ∼2); azithromycin was associated with lower odds of maternal infection (adjusted odds ratio of 0.4, 95% confidence interval 0.3-0.6. Despite preincision azithromycin-based extended spectrum antibiotic prophylaxis, postcesarean maternal infection remains a significant source of morbidity. Recognition of risk factors may help guide innovative prevention strategies.